Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Liquid Biopsies or Therapeutic Drug Monitoring for CYP Activity Profile Determination.

Authors:
Chris S Pridgeon Inger Johansson Magnus Ingelman-Sundberg

Clin Pharmacol Ther 2022 Jun 29. Epub 2022 Jun 29.

Department of Physiology and Pharmacology, Biomedicum B5, Karolinska Institutet, Stockholm, Sweden.

During pharmacotherapy, knowledge about the actual drug and metabolite concentrations in plasma is often critical. Individual dose adjustments can be performed based on pre-emptive genotyping of certain absorption, distribution, metabolism, and excretion (ADME) genes but also using therapeutic drug monitoring (TDM). Analyses of liquid biopsies for tumor-derived components are well-established and have been found to be a good complement to biopsy examinations. Recently, liquid biopsy-based quantification of cell-free RNA (cfRNA) in plasma exosomes was proposed as a proxy measurement for the expression of different hepatic ADME genes and for the rate of drug metabolism, constituting an alternative to TDM. In this study, we validated these findings by examining the correlation between mRNA expression of eight different CYP genes in liver and the corresponding rate of enzyme-specific drug metabolism in 96 donor-matched liver samples. Analyses of CYP-dependent drug metabolism in liver microsomes in comparison to the level of mRNA expression for the different CYP genes revealed a mean Pearson correlation coefficient of 0.28. The highest correlations (0.33-0.34) were obtained for CYP2D6 and CYP3A4 and the weakest correlations were observed for CYP1A2 and CYP2B6 (0.18-0.21). In all cases, the correlations obtained were too weak to demonstrate a predictive relationship, likely due to different regulatory and post-translational events controlling the rate of enzyme activity. Our results reinforce the notion that, whilst liquid biopsy-based approaches might have utility for prediction of hepatic CYP protein expression, they are not currently an important substitute for TDM.

Download full-text PDF

 Source
http://dx.doi.org/10.1002/cpt.2695DOI Listing
June 2022

Publication Analysis

Top Keywords

drug metabolism
12
mrna expression
8
cyp genes
8
therapeutic drug
8
drug monitoring
8
liquid biopsies
8
liquid biopsy-based
8
expression cyp
8
adme genes
8
drug
6
metabolism donor-matched
4
genes liver
4
liver corresponding
4
corresponding rate
4
rate enzyme-specific
4
enzyme-specific drug
4
liquid
4
donor-matched liver
4
samples analyses
4
analyses cyp-dependent
4

Keyword Occurance

Similar Publications

Mendelian Randomization Shows a Causal Effect of Low Vitamin D on Non-infectious Uveitis and Scleritis Risk.

Authors:
Gayatri Susarla Weilin Chan Ashley Li Samaneh Davoudi Tina Ahmadi Shaleen Sathe Lisa Tom George N Papaliodis Josep M Mercader Aaron Leong Lucia Sobrin

Am J Ophthalmol 2022 Aug 7. Epub 2022 Aug 7.

Retina Department, Massachusetts Eye and Ear Infirmary, Boston, MA, US. Electronic address:

Purpose: To investigate a causal relationship between Vitamin D levels and non-infectious uveitis and scleritis using Mendelian randomization (MR) techniques.

Design: Two-sample Mendelian randomization case-control study.

Methods: Setting: Biobank of an academic, integrated health care system. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Development of QSAR model using machine learning and molecular docking study of polyphenol derivatives against obesity as pancreatic lipase inhibitor.

Authors:
Shristi Modanwal Akhilesh Kumar Maurya Saurav Kumar Mishra Nidhi Mishra

J Biomol Struct Dyn 2022 Aug 10:1-12. Epub 2022 Aug 10.

Chemistry Laboratory, Department of Applied Sciences, Indian Institute of Information Technology Allahabad, Prayagraj, Uttar Pradesh, India.

In developed countries and developing countries, obesity/overweight is considered a major problem, in fact, it is now recognized as a major metabolic disorder. Additionally, obesity is connected with other metabolic diseases, including cardiovascular disorders, type 2 diabetes, some types of cancer, etc. Therefore, the development of novel drugs/medications for obesity is essential. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Tocolytics for delaying preterm birth: a network meta-analysis (0924).

Authors:
Amie Wilson Victoria A Hodgetts-Morton Ella J Marson Alexandra D Markland Eva Larkai Argyro Papadopoulou Arri Coomarasamy Aurelio Tobias Doris Chou Olufemi T Oladapo Malcolm J Price Katie Morris Ioannis D Gallos

Cochrane Database Syst Rev 2022 Aug 10;8:CD014978. Epub 2022 Aug 10.

Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research (IMSR), WHO Collaborating Centre for Global Women's Health Research, University of Birmingham, Birmingham, UK.

Background: Preterm birth is the leading cause of death in newborns and children. Tocolytic drugs aim to delay preterm birth by suppressing uterine contractions to allow time for administration of corticosteroids for fetal lung maturation, magnesium sulphate for neuroprotection, and transport to a facility with appropriate neonatal care facilities. However, there is still uncertainty about their effectiveness and safety. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Cytochrome P450 oxidoreductase variant A503V contributes to the increased CYP3A5 activity with tacrolimus .

Authors:
Yuan Gao Jingjing Ma

Expert Opin Drug Metab Toxicol 2022 Aug 10. Epub 2022 Aug 10.

Department of Pharmacy, Medical center of Soochow University, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, China.

Background: Tacrolimus is a calcineurin inhibitor with a strong efficacy in prevention of graft rejection after transplantation. It is well known that cytochrome P450 3A5 (CYP3A5) has a high metabolic capacity for tacrolimus, and mutations in human cytochrome P450 oxidoreductase (POR) cause altered CYP3A5 activity. Recently, clinical studies have revealed that contributes enhanced tacrolimus clearance in CYP3A5 expressers. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Chemotherapy and anticancer drugs adjustment in obesity: a narrative review.

Authors:
João Pedro Thimotheo Batista Lucas Alexandre Santos Marzano Renata Aguiar Menezes Silva Karla Emília de Sá Rodrigues Ana Cristina Simões E Silva

Curr Med Chem 2022 Aug 6. Epub 2022 Aug 6.

Laboratório Interdisciplinar de Investigação Médica (LIIM), Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), CEP 30.130-100, Avenida Professor Alfredo Balena, nº190/sl 281, Santa Efigênia, Belo Horizonte, MG, Brazil.

Background: Obese individuals have higher rates of cancer incidence and cancer-related mortality. The worse chemotherapy outcomes observed in this subset of patients are multifactorial, including the altered physiology in obesity and its impact on the pharmacokinetics, the possible increased risk of underdosing, and treatment-related toxicity.

Aim: The present review aimed to discuss recent data on physiology, providing just an overall perspective, and pharmacokinetic alterations in obesity concerning chemotherapy. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}